Efficacy of Botulinum toxin and Repetitive Transcranial Magnetic Stimulation in treating Cervical Dystonia: A Double-blind Placebo Controlled Trial

Not Applicable

Recruiting

• Conditions: Cervical Dystonia; Neurological - Other neurological disorders

• Registration Number: ACTRN12610000275066
• Lead Sponsor: Monash Medical Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-04-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Patients are to be recruited from the Botulinum Toxin Outpatient Clinics at the Monash Medical Centre. All consenting patients with clinical diagnosis of rotational cervical dystonia and stable requirements of Botulinum toxin in the previous 6 months will be included

Exclusion Criteria

Exclusion criteria will include those patients with intracranial metal objects or pacemakers, seizures or family history of seizures, pregnant women, those with known excessive alcohol use or serious medical conditions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores.[At baseline, immediately after repetitive transcranial magnetic stimulation treatment and at 1 and 4 months after treatment];Quality of life measures as measured by the The Short Form (36) Health Survey (SF-36)[At baseline, immediately after repetitive transcranial magnetic stimulation treatment and at 1 and 4 months after treatment]

Secondary Outcome Measures

Name	Time	Method
nil[nil]